Javascript verkar inte påslaget? - Vissa delar av Lunds universitets webbplats fungerar inte optimalt utan javascript, kontrollera din webbläsares inställningar.
Du är här

High-throughput proteomics using antibody microarrays: an update

Publiceringsår: 2007
Språk: Engelska
Sidor: 673-686
Publikation/Tidskrift/Serie: Expert Review of Molecular Diagnostics
Volym: 7
Nummer: 5
Dokumenttyp: Artikel i tidskrift
Förlag: Future Drugs Ltd


Antibody-based microarrays are a rapidly emerging technology that has advanced from the first proof-of-concept studies to demanding serum protein profiling applications during recent years, displaying great promise within disease proteomics. Miniaturized micro- and nanoarrays can be fabricated with an almost infinite number of antibodies carrying the desired specificities. While consuming only minute amounts of reagents, multiplexed and ultrasensitive assays can be performed targeting high- as well as low-abundance analytes in complex nonfractionated proteomes. The microarray images generated can then be converted into protein expression profiles or protein atlases, revealing a detailed composition of the sample. The technology will provide unique opportunities for fields such as disease diagnostics, biomarker discovery, patient stratification, predicting disease recurrence and drug target discovery. This review describes an update of high-throughput proteomics, using antibody-based microarrays, focusing on key technological advances and novel applications that have emerged over the last 3 years.


  • Immunology in the medical area
  • recombinant
  • proteomics
  • protein array
  • oncoproteomics
  • nanoarrays
  • disease proteomics
  • affinity proteomics
  • antibody microarrays
  • antibody microarray


  • CREATE Health
  • ISSN: 1744-8352

Box 117, 221 00 LUND
Telefon 046-222 00 00 (växel)
Telefax 046-222 47 20
lu [at] lu [dot] se

Fakturaadress: Box 188, 221 00 LUND
Organisationsnummer: 202100-3211
Om webbplatsen